LYMPHAZURIN (UNITED STATES SURGICAL CORPORATION)


Welcome to the PulseAid listing for the LYMPHAZURIN drug offered from UNITED STATES SURGICAL CORPORATION. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: UNITED STATES SURGICAL CORPORATION
NON-PROPRIETARY NAME: isosulfan blue
SUBSTANCE NAME: ISOSULFAN BLUE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-01-12
END MARKETING DATE: 0000-00-00


LYMPHAZURIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLYMPHAZURIN from UNITED STATES SURGICAL CORPORATION
LABELER NAME: UNITED STATES SURGICAL CORPORATION
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2012-01-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63261-250_2a25e7c7-d5f4-40b6-82b8-74aabc34b3e4
PRODUCT NDC: 63261-250
APPLICATION NUMBER: NDA018310

Other ISOSULFAN BLUE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationIsosulfan Blue
AuroMedics Pharma LLCIsosulfan Blue
Mylan Institutional LLCIsosulfan Blue
UNITED STATES SURGICAL CORPORATIONLYMPHAZURIN